NCT01247883View on ClinicalTrials.gov

A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Healthy

Interventions

DRUG

PF-04634817

single dose, 20mg, tablet

DRUG

PF-04634817

single dose, 20mg, solution

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

Collaborators (1)

Incyte Corporation

All Listed Sponsors

collaborator

Incyte Corporation

INDUSTRY

lead

Pfizer

INDUSTRY